V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240006835 | 240013447 | 1.65 | null | Curative (C) | 2014-11-29 | 2014-12-13 | LI-1 TRIAL | N | N | 240031720 | TRIAL |
| 240006836 | 240016001 | 1.67 | 83.7 | Palliative (P) | null | 2018-11-30 | Chlorambucil | 02 | N | 240031732 | CHLORAMBUCIL |
| 240006837 | 240016001 | 1.56 | 70 | Palliative (P) | 2016-05-17 | 2016-05-29 | Carboplatin AUC 6 - 10 | 2 | N | 240031732 | CARBOPLATIN |
| 240006838 | 240004303 | null | null | null | 2018-01-09 | 2018-02-09 | Carboplatin AUC 2 - 5 | N | N | 240031736 | CARBOPLATIN |
| 240006839 | 240010417 | 1.67 | 43 | Disease modification (D) | 2015-04-07 | 2015-04-21 | R Chlorambucil | N | N | 240031744 | CHLORAMBUCIL + RITUXIMAB |
| 240006840 | 240010417 | 0 | 68.3 | Palliative (P) | 2015-12-24 | 2016-01-03 | Bevacizumab+Carbo+Pacliaxel | N | N | 240031744 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006841 | 240004304 | 1.82 | 0 | Palliative (P) | 2013-06-29 | 2013-07-09 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240031748 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006842 | 240004305 | 1.61 | 78 | Palliative (P) | null | 2018-02-05 | Chlorambucil | N | N | 240031751 | CHLORAMBUCIL |
| 240006843 | 240004305 | null | 54 | Curative (C) | 2014-06-25 | 2014-06-28 | DA 3 + 10 | Y | null | 240031751 | DA |
| 240006844 | 240004305 | 1.51 | 47.7 | Palliative (P) | 2015-05-26 | 2015-05-26 | R Chlorambucil | N | N | 240031751 | CHLORAMBUCIL + RITUXIMAB |
| 240006845 | 240004306 | 1.8 | 85 | Palliative (P) | 2016-07-14 | 2016-07-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240031759 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006846 | 240004307 | 1.65 | 51 | Curative (C) | 2016-01-18 | 2016-01-18 | Chlorambucil | N | N | 240031761 | CHLORAMBUCIL |
| 240006847 | 240010419 | 1.55 | 58.7 | Palliative (P) | 2017-02-16 | 2017-02-17 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240031762 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006848 | 240013450 | 1.6 | null | Palliative (P) | 2017-09-02 | 2017-09-13 | CARBOPLATIN + ETOPOSIDE | 1 | Y | 240031765 | CARBOPLATIN + ETOPOSIDE |
| 240006849 | 240004308 | null | 56.8 | Curative (C) | null | 2013-08-01 | Carboplatin AUC 6 - 10 | 2 | N | 240031772 | CARBOPLATIN |
| 240006851 | 240004310 | 1.55 | 64.7 | Palliative (P) | 2014-01-01 | 2014-01-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240031776 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006852 | 240004311 | null | 75 | Neo-adjuvant (N) | null | 2013-03-05 | INTERLACE TRIAL | 02 | N | 240031787 | INTERLACE TRIAL |
| 240006853 | 240010420 | 1.85 | 87.1 | null | 2014-02-05 | 2014-04-02 | Chlorambucil | N | N | 240031788 | CHLORAMBUCIL |
| 240006854 | 240010420 | 1.64 | 61.9 | Palliative (P) | 2013-10-19 | 2013-10-19 | Hydroxycarbamide | N | N | 240031788 | HYDROXYCARBAMIDE |
| 240006855 | 240004312 | 1.67 | 58.4 | Neo-adjuvant (N) | 2015-07-31 | 2015-08-06 | Bendamustine +/- Prednisolone | N | N | 240031791 | BENDAMUSTINE |
| 240006856 | 240004313 | null | 107.1 | Palliative (P) | 2017-02-10 | 2017-02-11 | Chlorambucil | 02 | N | 240031793 | CHLORAMBUCIL |
| 240006857 | 240004313 | 1.66 | 43.7 | null | null | 2013-11-11 | Carboplatin AUC 6 - 10 | 02 | null | 240031793 | CARBOPLATIN |
| 240006858 | 240004314 | 1.85 | 36.8 | Palliative (P) | 2015-07-17 | 2015-08-08 | Bevacizumab+Carbo+Pacliaxel | N | N | 240031801 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006859 | 240004315 | 1.69 | 59.2 | null | 2013-07-02 | 2013-07-05 | Carboplatin + Etoposide IV 3 day | 02 | N | 240031804 | CARBOPLATIN + ETOPOSIDE |
| 240006860 | 240010422 | null | 73.65 | Curative (C) | 2016-05-28 | 2016-05-28 | Carboplatin + Etoposide IV 3 day | N | N | 240031805 | CARBOPLATIN + ETOPOSIDE |
| 240006861 | 240013452 | 1.75 | 60.7 | null | 2015-05-28 | 2015-05-28 | CYTARABINE + DAUNORUBICIN | N | Y | 240031811 | DA |
| 240006862 | 240004316 | 1.71 | 66.2 | Disease modification (D) | 2013-10-05 | 2013-10-25 | R Chlorambucil | 2 | N | 240031818 | CHLORAMBUCIL + RITUXIMAB |
| 240006863 | 240010423 | null | null | Curative (C) | 2017-11-29 | 2017-11-29 | DA 3+8 | null | null | 240031820 | DA |
| 240006864 | 240010423 | 1.55 | 61 | null | 2015-04-01 | 2015-04-02 | Chlorambucil | N | N | 240031820 | CHLORAMBUCIL |
| 240006865 | 240004317 | 0 | 50.7 | Palliative (P) | 2015-01-16 | 2015-01-16 | Hydroxycarbamide | N | N | 240031826 | HYDROXYCARBAMIDE |
| 240006866 | 240004318 | 1.68 | 59.7 | null | 2015-02-02 | 2015-02-02 | ALCL ALCL 99 Closed Pre Phase | N | N | 240031827 | NOT MATCHED |
| 240006867 | 240004319 | 1.72 | 94.7 | Palliative (P) | 2014-09-17 | 2014-09-17 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240031829 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006868 | 240004320 | 0 | null | Curative (C) | 2014-05-31 | 2014-06-06 | INTERLACE TRIAL | null | null | 240031833 | INTERLACE TRIAL |
| 240006869 | 240004321 | 1.64 | 61.6 | Disease modification (D) | 2017-03-13 | 2017-03-14 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240031840 | CHLORAMBUCIL + RITUXIMAB |
| 240006870 | 240004322 | 1.68 | 50.1 | Palliative (P) | 2016-09-06 | 2016-09-06 | CHLORAMBUCIL + RITUXIMAB | Y | N | 240031843 | CHLORAMBUCIL + RITUXIMAB |
| 240006871 | 240004322 | null | 117 | Palliative (P) | 2014-12-13 | 2015-10-15 | Chlorambucil | 02 | N | 240031843 | CHLORAMBUCIL |
| 240006872 | 240004322 | 1.64 | 82.6 | Adjuvant (A) | 2017-05-24 | 2017-06-04 | Bendamustine +/- Prednisolone | N | N | 240031843 | BENDAMUSTINE |
| 240006873 | 240004322 | 1.72 | null | Curative (C) | 2014-10-19 | 2014-10-19 | Chlorambucil | N | N | 240031843 | CHLORAMBUCIL |
| 240006874 | 240004323 | 0 | 62 | Curative (C) | 2016-05-31 | 2016-05-31 | INTERLACE TRIAL | 02 | N | 240031858 | INTERLACE TRIAL |
| 240006875 | 240004323 | 1.8 | 53.9 | null | 2014-11-09 | 2014-11-09 | CYTARABINE + DAUNORUBICIN | Y | N | 240031858 | DA |
| 240006876 | 240004324 | null | 55.1 | Palliative (P) | 2017-02-27 | 2017-04-03 | Bevacizumab+Carbo+Pacliaxel | N | N | 240031862 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240006877 | 240004325 | 1.83 | null | Palliative (P) | 2017-05-29 | 2017-06-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240031863 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240006878 | 240004326 | 1.63 | null | Curative (C) | 2017-03-28 | 2017-04-18 | BMT | N | N | 240031869 | NOT MATCHED |
| 240006879 | 240004327 | 1.74 | 102 | Adjuvant (A) | 2013-12-19 | 2013-12-23 | Carboplatin + Etoposide iv&po | Y | Y | 240031870 | CARBOPLATIN + ETOPOSIDE |
| 240006880 | 240010426 | 1.77 | 66.8 | Palliative (P) | 2018-06-06 | 2018-06-23 | CHLORAMBUCIL + RITUXIMAB | 1 | Y | 240031880 | CHLORAMBUCIL + RITUXIMAB |
| 240006881 | 240010426 | 1.68 | 68.7 | Palliative (P) | 2017-01-24 | 2017-02-09 | ALCL ALCL 99 Closed Pre Phase | N | N | 240031880 | NOT MATCHED |
| 240006882 | 240010426 | 1.65 | 50.2 | Palliative (P) | 2017-05-11 | 2017-05-11 | Chlorambucil | N | N | 240031880 | CHLORAMBUCIL |
| 240006883 | 240010426 | null | 98.6 | Neo-adjuvant (N) | 2015-10-16 | 2015-11-15 | null | N | N | 240031880 | NOT MATCHED |
| 240006884 | 240010426 | 1.87 | 75.2 | Disease modification (D) | 2016-11-07 | 2016-11-07 | R Chlorambucil | 2 | N | 240031880 | CHLORAMBUCIL + RITUXIMAB |
| 240006885 | 240010426 | 1.62 | 54.5 | Not known (9) | 2014-11-29 | 2014-12-13 | CARBOPLATIN + ETOPOSIDE | N | N | 240031880 | CARBOPLATIN + ETOPOSIDE |